Kun Han

661 total citations
32 papers, 483 citations indexed

About

Kun Han is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kun Han has authored 32 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kun Han's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (5 papers). Kun Han is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (5 papers). Kun Han collaborates with scholars based in China, United States and Singapore. Kun Han's co-authors include Daliu Min, Yan Zhou, Shuchen Lin, Zhihua Gan, Haiyan Hu, Su Yang, Yaling Wang, Yang Yao, Yongning Sun and Jianjun Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kun Han

24 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Han China 13 311 189 107 71 58 32 483
Sifeng Tao China 11 371 1.2× 210 1.1× 92 0.9× 80 1.1× 87 1.5× 16 645
Chunjie Wen China 15 316 1.0× 162 0.9× 105 1.0× 48 0.7× 32 0.6× 29 519
Wence Zhou China 8 248 0.8× 82 0.4× 101 0.9× 65 0.9× 43 0.7× 20 396
Tingyuan Lang China 13 227 0.7× 94 0.5× 102 1.0× 62 0.9× 43 0.7× 25 429
Tengxiang Chen China 12 294 0.9× 181 1.0× 70 0.7× 76 1.1× 41 0.7× 48 516
Wenfeng Li China 10 394 1.3× 113 0.6× 65 0.6× 85 1.2× 94 1.6× 20 531
Xiumei Zheng China 10 229 0.7× 167 0.9× 171 1.6× 67 0.9× 55 0.9× 25 533
Hao Shi China 14 244 0.8× 165 0.9× 105 1.0× 137 1.9× 40 0.7× 31 488

Countries citing papers authored by Kun Han

Since Specialization
Citations

This map shows the geographic impact of Kun Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Han more than expected).

Fields of papers citing papers by Kun Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Han. The network helps show where Kun Han may publish in the future.

Co-authorship network of co-authors of Kun Han

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Han. A scholar is included among the top collaborators of Kun Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Han. Kun Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhipeng, Chenyang Qiu, Shuzhen Wu, et al.. (2025). Nomogram based on CT imaging and clinical data to predict the efficacy of PD-1 inhibitors combined with chemotherapy in advanced gastric cancer. Frontiers in Immunology. 16. 1504387–1504387.
2.
Zhang, Jindong, et al.. (2025). Aptamer-based PSA biosensing technology: From nanomaterials to CRISPR-diagnostics technology. Talanta. 298(Pt A). 128871–128871.
3.
Wei, Chengcheng, et al.. (2025). Multi-omics identify ribosome related causal genes methylation, splicing, and expression in prostate cancer. Discover Oncology. 16(1). 740–740. 1 indexed citations
4.
Luo, Yu, Chengcheng Wei, Zhangcheng Liu, et al.. (2025). A novel bone metastasis-related gene signature for predicting prognosis, anti-androgen resistance, and drug choice in prostate cancer. Journal of bone oncology. 52. 100673–100673.
6.
Wang, Jianhao, et al.. (2024). Screening of hub genes for sepsis-induced myopathy by weighted gene co-expression network analysis and protein-protein interaction network construction. BMC Musculoskeletal Disorders. 25(1). 834–834. 2 indexed citations
7.
Sun, Xingxing, Hongling Zhu, Qingyu Chen, et al.. (2024). Delivery of IL-12 by neoantigen-reactive T cells promotes antitumor immunity in murine osteosarcoma mode. PubMed. 5(1). ltae010–ltae010.
9.
Tian, Cong, Tingyuan Lang, Jiangfeng Qiu, et al.. (2020). SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1. Cancer Cell International. 20(1). 579–579. 18 indexed citations
10.
Tian, Cong, et al.. (2020). Long Non-coding RNA MRUL Contributes to Osteosarcoma Progression Through the miR-125a-5p/FUT4 Axis. Frontiers in Genetics. 11. 672–672. 5 indexed citations
11.
Tian, Cong, Hui Zhang, Kun Han, et al.. (2020). Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma. Biomedicine & Pharmacotherapy. 128. 110201–110201. 33 indexed citations
12.
Yang, Su, Yan Zhou, Yuanjue Sun, et al.. (2018). Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1. Journal of Molecular Medicine. 97(1). 49–61. 41 indexed citations
13.
Wang, Yaling, Yuan Shen, Kun Han, et al.. (2017). Pterostilbene suppresses human endometrial cancer cells in vitro by down-regulating miR-663b. Acta Pharmacologica Sinica. 38(10). 1394–1400. 24 indexed citations
14.
Zhang, Jianjun, Yan Zhou, Kun Han, et al.. (2016). Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA‐221. Evidence-based Complementary and Alternative Medicine. 2016(1). 7319464–7319464. 18 indexed citations
15.
Han, Kun, Wei Meng, Jianjun Zhang, et al.. (2016). Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301. OncoTargets and Therapy. 9. 3085–3085. 61 indexed citations
16.
Gan, Zhihua, Shuchen Lin, Kun Han, et al.. (2015). Bilateral spontaneous pneumothorax in an osteosarcoma patient with pulmonary metastases: A case report. Oncology Letters. 11(2). 1179–1180. 6 indexed citations
17.
Lin, Shuchen, Zhihua Gan, Kun Han, Yang Yao, & Daliu Min. (2015). Metastasis of myxoid liposarcoma to fat-bearing areas: A case report of unusual metastatic sites and a hypothesis. Oncology Letters. 10(4). 2543–2546. 9 indexed citations
18.
Han, Kun, Wei‐Xiang Qi, Zhihua Gan, et al.. (2013). Prognostic Value of Ezrin in Solid Tumors: A Meta-Analysis of the Literature. PLoS ONE. 8(7). e68527–e68527. 8 indexed citations
19.
Han, Kun, Yuanjue Sun, Jianjun Zhang, et al.. (2012). Cyclophosphamide‐hydroxycamptothecin as second‐line chemotherapy for advanced Ewing's sarcoma: Experience of a single institution. Asia-Pacific Journal of Clinical Oncology. 10(2). e114–7. 4 indexed citations
20.
Han, Kun, Yuanjue Sun, Jianjun Zhang, et al.. (2012). Retrospective clinical analysis of MAID protocol as first-line treatment on 137 metastatic soft-tissue sarcomas patients. The Chinese-German Journal of Clinical Oncology. 11(2). 117–120. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026